Bio Protocol vs Morpho — how do they compare? Bio Protocol trades at Rp515.91 (market cap Rp1,16T, Rp252,63M 24h volume), while Morpho trades at Rp36,235 (market cap Rp18,46T, Rp370,92M 24h volume). The key difference: Morpho is far larger — about 15.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 515,6M / 1B MORPHO (52%) for Morpho. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Morpho for 15 Days on average.
| BIO | MORPHO | |
|---|---|---|
Market Cap | Rp1,16T | Rp18,46T |
Volume (24h) | Rp252,63M | Rp370,92M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 515,6M / 1B MORPHO (52%) |
Typical Hold Time | 16 Days | 15 Days |
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Morpho is an open, efficient, and trustless platform designed for earning yield and borrowing assets. Lenders utilize Morpho Vaults to maximize their returns, while borrowers gain access to assets through Morpho Markets. Its permissionless infrastructure empowers developers and businesses to create markets, curate vaults, and build applications. With immutable contracts, isolated lending markets, improved interest rates, and low gas fees, Morpho offers efficiency, flexibility, and a developer-friendly environment.
Read more on MORPHO →